Gulo, Jonalyn .

HRN: 27-03-86  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2025
CEFUROXIME 1.5GM (VIAL)
04/27/2025
04/29/2025
IV
1.5
Q8hr X 4 Doses
Sp CS
Waiting Final Action 
04/27/2025
CEFUROXIME 500MG (TAB)
04/30/2025
05/06/2025
ORAL
500mg
BID
Sp CS
Waiting Final Action 
04/27/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/27/2025
04/27/2025
IV
500mg
Now
Sp CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: